W4239624178
Manja Wobus, Robin Kuns, Irena Sheyn et al. · Applied Immunohistochemistry · 2002
Cited by 1 works. doi:10.1097/00022744-200209000-00010
Authors
References
- Biochemical and Clinical Implications of the ErbB/HER Signaling Network of Growth Factor Receptors
- CD44: Structure, Function and Association with the Malignant Process
- Endometrial Carcinoma
- Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage disease
- Multivariable analysis of DNA ploidy, p53, and HER-2/neu as prognostic factors in endometrial cancer
- Interaction between the Adhesion Receptor, CD44, and the Oncogene Product, p185 , Promotes Human Ovarian Tumor Cell Activation
- HER-2/neu Amplification and Overexpression in Endometrial Carcinoma
- Cd44 Enhances Neuregulin Signaling by Schwann Cells
- Expression of p53, transforming growth factor alpha, epidermal growth factor receptor, and c-erbB-2 in endometrial carcinoma and correlation with survival and known predictors of survival
- Prognostic value of epidermal growth factor receptor expression in endometrioid endometrial carcinoma